XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jul. 31, 2022
Aug. 01, 2021
Cash flows from operating activities:    
Net income $ 89,644 $ 56,429
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 14,998 15,221
Amortization of right-of-use assets 2,302 2,182
Investment impairments and credit loss reserves, net (405) 714
Accretion of deferred financing costs and debt discount 241 241
Deferred income taxes 261 719
Share-based compensation 24,143 23,356
(Gain) loss on disposition of business operations and assets (17,978) 2
Equity in net gains of equity method investments (307) (752)
Corporate-owned life insurance, net 831 3,626
Changes in assets and liabilities:    
Accounts receivable, net 402 (2,629)
Inventories (15) (15,537)
Other assets 2,836 2,434
Accounts payable 5,676 2,274
Accrued liabilities 7,230 2,874
Other liabilities (2,530) (5,555)
Net cash provided by operating activities 127,329 85,599
Cash flows from investing activities:    
Proceeds from sales of property, plant and equipment 0 42
Purchase of property, plant and equipment (15,583) (12,732)
Proceeds from sale of investments 2,275 0
Purchase of investments (3,288) (3,177)
Proceeds from sale of business, net of cash disposed 26,812 0
Proceeds from corporate-owned life insurance 2,676 0
Premiums paid for corporate-owned life insurance (2,676) 0
Net cash provided by (used in) investing activities 10,216 (15,867)
Cash flows from financing activities:    
Proceeds from revolving line of credit 10,000 0
Payments of revolving line of credit (10,000) (4,000)
Payment for employee share-based compensation payroll taxes (5,616) (7,289)
Proceeds from exercise of stock options 620 2,323
Repurchase of common stock (50,000) (67,000)
Net cash used in financing activities (54,996) (75,966)
Net increase (decrease) in cash and cash equivalents 82,549 (6,234)
Cash and cash equivalents at beginning of period 279,601 268,891
Cash and cash equivalents at end of period 362,150 262,657
Supplemental disclosure of cash flow information:    
Interest paid 1,931 2,120
Income taxes paid 5,375 3,163
Non-cash investing and financing activities:    
Accounts payable related to capital expenditures 3,384 2,872
Conversion of notes into equity $ 0 $ 626